These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17260953)

  • 41. Immunotherapy in systemic primary (AL) amyloidosis using amyloid-reactive monoclonal antibodies.
    Solomon A; Weiss DT; Wall JS
    Cancer Biother Radiopharm; 2003 Dec; 18(6):853-60. PubMed ID: 14969598
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Decreased amyloidogenicity caused by mutational modulation of surface properties of the immunoglobulin light chain BRE variable domain.
    Kobayashi Y; Tsutsumi H; Abe T; Ikeda K; Tashiro Y; Unzai S; Kamikubo H; Kataoka M; Hiroaki H; Hamada D
    Biochemistry; 2014 Aug; 53(31):5162-73. PubMed ID: 25062800
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Further characterization of a monoclonal antibody recognizing apolipoprotein E peptides in amyloid deposits.
    Yamada T; Wakabayashi K; Kakihara T; Gejyo F; Takahashi H; Itoh Y
    Ann Clin Lab Sci; 1997; 27(4):276-81. PubMed ID: 9210972
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutations can cause light chains to be too stable or too unstable to form amyloid fibrils.
    Marin-Argany M; Güell-Bosch J; Blancas-Mejía LM; Villegas S; Ramirez-Alvarado M
    Protein Sci; 2015 Nov; 24(11):1829-40. PubMed ID: 26300552
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complete amino acid sequence determinations demonstrate identity of the urinary Bence Jones protein (BJP-DIA) and the amyloid fibril protein (AL-DIA) in a case of AL-amyloidosis.
    Klafki HW; Kratzin HD; Pick AI; Eckart K; Karas M; Hilschmann N
    Biochemistry; 1992 Mar; 31(12):3265-72. PubMed ID: 1554711
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of anti-(beta2 microglobulin) mAb to study formation of amyloid fibrils.
    Stoppini M; Bellotti V; Mangione P; Merlini G; Ferri G
    Eur J Biochem; 1997 Oct; 249(1):21-6. PubMed ID: 9363749
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Localization and fine mapping of antigenic sites on the nucleocapsid protein N of porcine reproductive and respiratory syndrome virus with monoclonal antibodies.
    Meulenberg JJ; van Nieuwstadt AP; van Essen-Zandbergen A; Bos-de Ruijter JN; Langeveld JP; Meloen RH
    Virology; 1998 Dec; 252(1):106-14. PubMed ID: 9875321
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Substantial Structural Conversion of the Native Monomer Leads to in-Register Parallel Amyloid Fibril Formation in Light-Chain Amyloidosis.
    Lecoq L; Wiegand T; Rodriguez-Alvarez FJ; Cadalbert R; Herrera GA; Del Pozo-Yauner L; Meier BH; Böckmann A
    Chembiochem; 2019 Apr; 20(8):1027-1031. PubMed ID: 30565364
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Production and characterization of monoclonal antibodies to porcine immunoglobulin gamma, alpha, and light chains.
    Paul PS; Mengeling WL; Malstrom CE; Van Deusen RA
    Am J Vet Res; 1989 Apr; 50(4):471-9. PubMed ID: 2469366
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pattern recognition with a fibril-specific antibody fragment reveals the surface variability of natural amyloid fibrils.
    Haupt C; Bereza M; Kumar ST; Kieninger B; Morgado I; Hortschansky P; Fritz G; Röcken C; Horn U; Fändrich M
    J Mol Biol; 2011 May; 408(3):529-40. PubMed ID: 21376731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Both the environment and somatic mutations govern the aggregation pathway of pathogenic immunoglobulin light chain.
    Davis DP; Gallo G; Vogen SM; Dul JL; Sciarretta KL; Kumar A; Raffen R; Stevens FJ; Argon Y
    J Mol Biol; 2001 Nov; 313(5):1021-34. PubMed ID: 11700059
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structural relationship of lambda-type light chains with AL amyloidosis.
    Alim MA; Yamaki S; Hossain MS; Takeda K; Yamagata F; Takashi I; Shinoda T
    Clin Immunol; 1999 Mar; 90(3):399-403. PubMed ID: 10075869
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Specificity mapping of human anti-T cell receptor monoclonal natural antibodies: defining the properties of epitope recognition promiscuity.
    Robey IF; Edmundson AB; Schluter SF; Yocum DE; Marchalonis JJ
    FASEB J; 2002 May; 16(7):642-52. PubMed ID: 11978728
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The amino acid sequence of the glycosylated amyloid immunoglobulin light chain protein AL MS.
    Omtvedt LA; Husby G; Cornwell GG; Kyle RA; Sletten K
    Scand J Immunol; 1997 May; 45(5):551-6. PubMed ID: 9160102
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A case of primary immunoglobulin light chain amyloidosis with a delayed appearance of Bence Jones protein in urine.
    Kurusu A; Yamada T; Yamaji K; Nishitani M; Tashiro K; Maeda K; Horikoshi S; Shirato I; Rinno H; Tomino Y
    Nephrology (Carlton); 2004 Jun; 9(3):122-5. PubMed ID: 15189172
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction in mice of human light-chain-associated amyloidosis.
    Solomon A; Weiss DT; Pepys MB
    Am J Pathol; 1992 Mar; 140(3):629-37. PubMed ID: 1546744
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Two monoclonal antibodies to precisely the same epitope of type II collagen select non-crossreactive phage clones by phage display: implications for autoimmunity and molecular mimicry.
    Xu Y; Ramsland PA; Davies JM; Scealy M; Nandakumar KS; Holmdahl R; Rowley MJ
    Mol Immunol; 2004 Jun; 41(4):411-9. PubMed ID: 15163538
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nanobodies counteract the toxicity of an amyloidogenic light chain by stabilizing a partially open dimeric conformation.
    Broggini L; Barzago MM; Speranzini V; Schulte T; Sonzini F; Giono M; Romeo M; Milani P; Caminito S; Mazzini G; Rognoni P; Merlini G; Pappone C; Anastasia L; Nuvolone M; Palladini G; Diomede L; Ricagno S
    J Mol Biol; 2023 Dec; 435(24):168320. PubMed ID: 37865287
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antigenicity and cross-reactivity of denatured fibril proteins of primary, secondary, and myeloma associated amyloids.
    Benson MD; Skinner M; Cohen AS
    J Lab Clin Med; 1975 Apr; 85(4):650-9. PubMed ID: 47375
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exploring the sequence features determining amyloidosis in human antibody light chains.
    Rawat P; Prabakaran R; Kumar S; Gromiha MM
    Sci Rep; 2021 Jul; 11(1):13785. PubMed ID: 34215782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.